{"slideshow_credits": null, "snippet": "Celgene, a New Jersey biotechnology company, will pay $232 a share for Receptos, which is developing a drug for autoimmune diseases.", "abstract": "Biotech firm Celgene agrees to buy Receptos for $7.2 billion.", "section_name": "Business Day", "print_page": "3", "document_type": "article", "byline": {"person": [{"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 1, "organization": ""}], "original": "By ANDREW POLLACK"}, "web_url": "http://www.nytimes.com/2015/07/15/business/dealbook/celgene-agrees-to-7-2-billion-deal-for-receptos.html", "lead_paragraph": "Celgene, a New Jersey biotechnology company, will pay $232 a share for Receptos, which is developing a drug for autoimmune diseases.", "headline": {"main": "Celgene Agrees to $7.2 Billion Deal for Receptos", "print_headline": "Celgene Agrees to Buy Autoimmune Drug Maker"}, "_id": "55a584c438f0d8361af04699", "word_count": "489", "multimedia": [], "pub_date": "2015-07-15T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Celgene Corporation", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Receptos Inc.", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Autoimmune Diseases", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}